76 related articles for article (PubMed ID: 3958122)
1. Early normalization of luteinizing hormone pulsatility after successful transsphenoidal surgery in women with microprolactinomas.
Stevenaert A; Beckers A; Vandalem JL; Hennen G
J Clin Endocrinol Metab; 1986 May; 62(5):1044-7. PubMed ID: 3958122
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC
J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
[TBL] [Abstract][Full Text] [Related]
3. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
[TBL] [Abstract][Full Text] [Related]
4. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
[TBL] [Abstract][Full Text] [Related]
5. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
[TBL] [Abstract][Full Text] [Related]
6. The source of pulsatile secretion of progesterone during the human follicular phase.
Judd S; Terry A; Petrucco M; White G
J Clin Endocrinol Metab; 1992 Feb; 74(2):299-305. PubMed ID: 1730808
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone pulsatile administration restores luteinizing hormone pulsatility and normal testosterone levels in males with hyperprolactinemia.
Bouchard P; Lagoguey M; Brailly S; Schaison G
J Clin Endocrinol Metab; 1985 Feb; 60(2):258-62. PubMed ID: 3917455
[TBL] [Abstract][Full Text] [Related]
8. Parallelism in the luteinizing hormone responses to opioid and dopamine antagonists in hyperprolactinemic women with pituitary microadenoma.
Seki K; Kato K; Shima K
J Clin Endocrinol Metab; 1986 Nov; 63(5):1225-8. PubMed ID: 3760121
[TBL] [Abstract][Full Text] [Related]
9. Prolactin-lowering effect of luteinizing hormone-releasing hormone agonist administration in prolactinoma patients.
Rubio MA; Cabranes JA; Schally AV; Charro AL
J Clin Endocrinol Metab; 1989 Aug; 69(2):444-7. PubMed ID: 2526819
[TBL] [Abstract][Full Text] [Related]
10. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.
Arafah BM
J Clin Endocrinol Metab; 1986 Jun; 62(6):1173-9. PubMed ID: 3009521
[TBL] [Abstract][Full Text] [Related]
11. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
Christman GM; Randolph JF; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
[TBL] [Abstract][Full Text] [Related]
12. Pulsatile secretion of luteinizing hormone and prolactin in lactating and nonlactating women and the response to naltrexone.
Kremer JA; Borm G; Schellekens LA; Thomas CM; Rolland R
J Clin Endocrinol Metab; 1991 Feb; 72(2):294-300. PubMed ID: 1899421
[TBL] [Abstract][Full Text] [Related]
13. Effects of hyperprolactinemia on prolactin and LH pulsatile pattern in female rats.
Lafuente A; Marcó J; Esquifino AI
Rev Esp Fisiol; 1992 Dec; 48(4):291-6. PubMed ID: 1302899
[TBL] [Abstract][Full Text] [Related]
14. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
Nippoldt TB; Reame NE; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
[TBL] [Abstract][Full Text] [Related]
15. Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.
Barbarino A; De Marinis L; Maira G; Menini E; Anile C
J Clin Endocrinol Metab; 1978 Nov; 47(5):1148-51. PubMed ID: 122421
[TBL] [Abstract][Full Text] [Related]
16. Effect of chronic opioid antagonism on the hypothalamic-pituitary-ovarian axis in hyperprolactinemic women.
Matera C; Freda PU; Ferin M; Wardlaw SL
J Clin Endocrinol Metab; 1995 Feb; 80(2):540-5. PubMed ID: 7852517
[TBL] [Abstract][Full Text] [Related]
17. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
[TBL] [Abstract][Full Text] [Related]
18. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
Nicoletti I; Ambrosi F; Giammartino C; Fedeli L; Mannarelli C; Filipponi P
Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473
[TBL] [Abstract][Full Text] [Related]
19. Restoration of LH pulsatility in patients with prolactinomas after trans-sphenoidal surgery.
Koizumi K; Aono T; Koike K; Kurachi K
Acta Endocrinol (Copenh); 1984 Dec; 107(4):433-8. PubMed ID: 6440387
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of gonadotropin and prolactin release by dopamine: effect of endogenous estradiol levels.
Judd SJ; Rakoff JS; Yen SS
J Clin Endocrinol Metab; 1978 Sep; 47(3):494-8. PubMed ID: 122409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
